Lessee, Operating Lease, Liability, to be Paid, Year Four of CRESCENT BIOPHARMA, INC. from 31 Mar 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
CRESCENT BIOPHARMA, INC. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four in USD history and change rate from 31 Mar 2019 to 31 Dec 2025.
  • CRESCENT BIOPHARMA, INC. Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending 31 Dec 2025 was $107,000.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Four, YoY Quarterly Change (%)

CRESCENT BIOPHARMA, INC. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $107,000 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 $107,000 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $107,000 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q2 2020 $940,793 -$165,074 -15% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $940,842 -$165,025 -15% 31 Mar 2020 10-Q 01 May 2020 2020 Q1
Q4 2019 $940,842 31 Dec 2019 10-K 28 Feb 2020 2019 FY
Q3 2019 $1,105,867 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 $1,105,867 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 $1,105,867 31 Mar 2019 10-Q 02 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.